ACA
ARKG icon

Aptus Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Aptus Capital Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5K Sell
630
-2,759
-81% -$87.9K ﹤0.01% 1475
2026
Q1 		$89.5K Sell
3,389
-58
-2% -$1.7K ﹤0.01% 1175
2025
Q4 		$99.9K Hold
3,447
– – ﹤0.01% 1180
2025
Q3 		$95.7K Hold
3,447
– – ﹤0.01% 1133
2025
Q2 		$83.9K Hold
3,447
– – ﹤0.01% 1110
2025
Q1 		$71.6K Buy
3,447
+2,960
+608% +$74.4K ﹤0.01% 1062
2024
Q4 		$11.5K Sell
487
-33
-6% -$812 ﹤0.01% 1269
2024
Q3 		$13.3K Hold
520
– – ﹤0.01% 1074
2024
Q2 		$12.2K Hold
520
– – ﹤0.01% 1013
2024
Q1 		$15K Sell
520
-5
-1% -$150 ﹤0.01% 997
2023
Q4 		$17.2K Sell
525
-5,513
-91% -$150K ﹤0.01% 757
2023
Q3 		$168K Buy
6,038
+275
+5% +$8.99K ﹤0.01% 582
2023
Q2 		$196K Sell
5,763
-1,175
-17% -$36.9K ﹤0.01% 487
2023
Q1 		$209K Buy
6,938
+4,629
+200% +$143K 0.01% 463
2022
Q4 		$65.2K Buy
2,309
+1,443
+167% +$45.8K ﹤0.01% 572
2022
Q3 		$28K Buy
866
+684
+376% +$25.1K ﹤0.01% 592
2022
Q2 		$6K Hold
182
– – ﹤0.01% 596
2022
Q1 		$8K Sell
182
-299
-62% -$14.3K ﹤0.01% 617
2021
Q4 		$29K Sell
481
-55
-10% -$3.8K ﹤0.01% 450
2021
Q3 		$40K Sell
536
-1,512
-74% -$127K ﹤0.01% 425
2021
Q2 		$190K Buy
2,048
+195
+11% +$16.6K 0.01% 361
2021
Q1 		$165K Buy
1,853
+591
+47% +$58.6K 0.01% 346
2020
Q4 		$117K Buy
+1,262
New +$101K 0.01% 331

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Aptus Capital Advisors's ARKG Position: Q2 2026 in Review

Aptus Capital Advisors reduced its ARK Genomic Revolution ETF (ARKG) stake by 81% in Q2 2026, selling an estimated $87.9K and leaving 630 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1475.

Aptus Capital Advisors first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $209K in Q1 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Aptus Capital Advisors held 630 shares of ARK Genomic Revolution ETF worth $26.5K as of Q2 2026.
  • Aptus Capital Advisors sold 2,759 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $87.9K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1475 holding.
  • Aptus Capital Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • Aptus Capital Advisors's ARK Genomic Revolution ETF position peaked at $209K in Q1 2023.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.